APT Medical Inc.
688617
Rank in Stocks
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Share Price
$38.62
Market Cap
$5.47B
Change (1 day)
0.19%
Change (1 year)
-17.07%
Country
CN
Trade APT Medical Inc. (688617)
Category
Healthcare
P/E ratio for APT Medical Inc. (688617)
P/E ratio as of October 2026 TTM: 38.78
According to APT Medical Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 38.78. At the end of 2024 the company had a P/E ratio of 53.81.
P/E ratio history for APT Medical Inc. from 2017 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 38.78 | -7.23% |
| 2025 | 41.80 | -22.31% |
| 2024 | 53.81 | 11.78% |
| 2023 | 48.14 | -16.88% |
| 2022 | 57.91 | -34.44% |
| 2021 | 88.33 | -47.39% |
| 2020 | 167.88 | -25.67% |
| 2019 | 225.87 | -73.94% |
| 2018 | 866.80 | 60.40% |
| 2017 | 540.40 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 32.34 | -16.61% |
US
|
|
| 23.19 | -40.21% |
IE
|
|
| 31.68 | -18.31% |
US
|
|
| 17.95 | -53.72% |
US
|
|
| 21.09 | -45.61% |
DE
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.